SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"
Public ClinicalTrials.gov record NCT04033367. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Double-blind, Placebo-controlled Study Evaluating the Effect of Dupilumab on Sleep in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)
Study identification
- NCT ID
- NCT04033367
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Sanofi
- Industry
- Enrollment
- 188 participants
Conditions and interventions
Conditions
Interventions
- Dupilumab Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 21, 2019
- Primary completion
- Oct 5, 2021
- Completion
- Oct 5, 2021
- Last update posted
- Sep 16, 2025
2019 – 2021
United States locations
- U.S. sites
- 8
- U.S. states
- 6
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site Number :8400012 | North Little Rock | Arkansas | 72117 | — |
| Investigational Site Number :8400002 | Redwood City | California | 94063 | — |
| Investigational Site Number :8400001 | Rolling Hills Estates | California | 90274 | — |
| Investigational Site Number :8400013 | Colorado Springs | Colorado | 80907 | — |
| Investigational Site Number :8400005 | Denver | Colorado | 80230 | — |
| Investigational Site Number :8400003 | Sarasota | Florida | 34239 | — |
| Investigational Site Number :8400007 | Medford | Oregon | 97504 | — |
| Investigational Site Number :8400008 | Charleston | South Carolina | 29407 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04033367, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 16, 2025 · Synced May 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04033367 live on ClinicalTrials.gov.